References
- Barral‐Neto M., Machado P., Barral A. Human cutaneous leishmaniasis: recent advances in physiopathology and treatment. Eur. J. Dermatol. 1995; 5: 104–113
- Berman J. D. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 1997; 24: 684–703
- El‐On J., Jacobs G. P., Weinrauch L. Topical chemotherapy of cutaneous leishmaniasis. Parasitol. Today 1988; 4(3)76–81
- Olson L. L., Pick J., Ellis W. Y., Lim P. A chemical assessment and HPLC assay validation of bulk paromomycin sulfate. J. Pharm. Biomed. Anal. 1997; 15: 783–793, [CSA]
- Soto J., Fuya P., Herrera R., Berman J. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study. Clin. Infect. Dis. 1998; 26: 56–58
- Hepburn N. C. Cutaneous leishmaniasis. Clin. Exp. Dermatol. 2000; 25: 363–370, [CSA]
- El‐On J., Jacobs G. P., Witztum E., Greenblatt C. L. Development of topical treatment by Leishmania major in experimental animals. Antimicrob. Agents Chemother. 1984; 26(2)745–751, [CSA]
- Garnier T., Croft S. L. Topical treatment for cutaneous leishmaniasis. Curr. Opin. Investig. Drugs 2002; 3(4)538–544, [CSA]
- Plessis J., Weiner N., Müller D. G. The influence of in vivo treatment of skin with liposomes on the topical absorption of a hydrophilic and a hydrophobic drug in vitro. Int. J. Pharm. 1994; 103: R1–R5
- Honzak L., Šentjurc M., Swartz H. M. In vivo EPR of topical delivery of a hydrophilic substance encapsulated in multilamellar liposomes applies to the skin of hairless and normal mice. J. Control. Release 2000; 66: 221–228, [CSA]
- Kim M. K., Chung S. J., Lee M. H., Cho A. R., Shim C. K. Targeted and sustained delivery of hydrocortisone to normal and stratum corneum‐removed skin without enhanced skin absorption using a liposome gel. J. Control. Release 1997; 46(3)243–251
- Flynn G. L., Durrheim H., Higuchi W. I. Permeation of hairless mouse skin II: membrane sectioning techniques and influence on alkanol permeabilities. J. Pharm. Sci. 1981; 70(1)52–56
- Belloli C., Crescenzo G., Carli S., Villa R., Sonzogni O., Carelli G., Ormas P. Pharmacokinetics and dosing regimen of aminosidine in the dog. Vet. Res. Commun. 1996; 20(6)533–541, [CSA]
- New R. R.C. Introduction. Liposomes, a practical approach. R. R.C. New. Oxford University Press, New York 1990, 299 pp.
- Coderch L., Fonollosa J., Pera M., Estelrich J., Maza A. Influence of cholesterol on liposome fluidity by EPR relationship with percutaneous absorption. J. Control. Release 2000; 68(1)85–95, [CSA]
- El Maghraby G. M.M., Willians A. C., Barry B. W. Skin delivery of oestradiol from deformable and traditional vesicles: mechanistic studies. J. Pharm. Pharmacol. 1999; 51: 1123–1134
- El Maghraby G. M.M., Willians A. C., Barry B. W. Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. Int. J. Pharm. 2000; 204: 159–169
- Egbaria K., Weiner N. Liposomes as a topical drug delivery system. Adv. Drug Deliv. Rev. 1990; 5: 287–300
- Coderch L., Oliva M., Pons M., Maza A., Manich A. M., Parra J. L. Percutaneous penetration of liposomes using the tape stripping technique. Int. J. Pharm. 1996; 139: 197–203
- Kirjavainen M., Urtti A., Koskela R. V., Kiesvaara J., Mönkkönen J. Phospholipids affect stratum corneum lipid bilayer fluidity and drug partitioning into the bilayers. Eur. J. Pharm. Sci. 1999; 7: 279–286, [CSA]
- Touitou E., Junginger H. E., Weiner T., Nagai T., Mezei M. Liposomes as carriers for the topical and transdermal delivery, symposium review. J. Pharm. Sci. 1994; 83(9)1189–1203
- Imbert D., Wickett R. R. Topical delivery with liposomes. Cosmet. Toilet. 1995; 110(9)32–44